A commercial-stage 
pharmaceutical company, 
developing drugs 
through cutting-edge 
drug delivery technologies

Who we are

Stay Informed: Upcoming IR Events & Financial Calendar

 

 

 

Calendar – All Events

Press releases & news

All press releases

Annual and Sustainability Report 2024

  • Orexo Overview: Insights covering areas such as operations, markets and investment themes, as well as the CEO's comments and the company’s strategic direction.
  • Reports: The Board of Directors Report (incl. the Sustainability Report), the Corporate Governance Report, and Financial Reports and Notes.

Discover

Who we are

Orexo is a commercial-stage pharmaceutical company with an international footprint. We are passionate about improving people's lives by offering innovative treatment solutions. Today, we develop pharmaceuticals based on proprietary drug delivery technologies, the same vision as when it all started in Uppsala, Sweden, 30 years ago.

Learn about our history

AmorphOX® – a world-class powder technology for cutting-edge drug delivery

Discover AmorphOX

Innovative treatments advancing health and well-being across diverse portfolio

Review solutions

Based on the AmorphOX technology we are developing new medications, e.g. OX640 - an intranasal epinephrine medication for allergic reactions 

Discover pipeline

Latest report

Report archive

Orexo´s SOCIAL Corporate Bond

Use of proceeds, March – December 2024, and KPI deliverables  

 

Go to the Social Financing Report 2025

Meaningful sustainable outcomes for people, societies and our planet

Explore sustainability

Orexo is committed to the UN Global Compact corporate responsibility initiative and its principles in the areas of human rights, labor, environment and anti-corruption. Read more on www.unglobalcompact.org.